Q&A With Paul Hudson of AstraZeneca US: 'Excitement' in Diabetes Treatment Progress

With so many people affected by diabetes finding the right treatment for the individual patients is becoming a key factor in care.

With so many people affected by diabetes finding the right treatment for the individual patients is becoming a key factor in care.

Paul Hudson, President of AstraZeneca US discussed some of the work the company is doing during the American Diabetes Association's 75th Annual Scientific Sessions in Boston. Hudson said much of the excitement centers around Forxiga which can be used in combination therapy.